JVAL - ETF AI Analysis
Top Page
JPMorgan U.S. Value Factor ETF (JVAL)
JVAL, the JPMorgan U.S. Value Factor ETF, earns a solid overall rating thanks to its heavy exposure to financially strong, innovation-focused leaders like Apple, Microsoft, and Alphabet, which benefit from growth in cloud, AI, and digital services. Semiconductor names such as Micron, Nvidia, Broadcom, and Lam Research also support the rating with positive earnings and AI-related growth, though their high valuations and some bearish or mixed technical signals introduce risk. The main risk factor is the fund’s concentration in large U.S. tech and semiconductor companies, which can make performance more sensitive to shifts in market sentiment, regulation, or growth expectations in these sectors.
JVAL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.05B
- Region
- North America
- Expense Ratio
- 0.12%
- Beta
- 0.95
- Issuer
- JPMorgan
- Inception Date
- Nov 08, 2017
- Dividend Yield
- 1.57%
- Asset Class
- Equity
- Index Tracked
- JP Morgan US Value Factor Index
JVAL Summary
JVAL is the JPMorgan U.S. Value Factor ETF, which follows the JP Morgan US Value Factor Index. It focuses on large U.S. companies that look undervalued based on basics like earnings, dividends, and cash flow. The fund is heavily invested in technology and other major sectors, and holds well-known names such as Apple and Microsoft. Someone might invest in JVAL to get broad exposure to established U.S. companies with potential for long-term growth at reasonable prices. A key risk is that these stocks can still go up and down with the overall stock market, especially tech shares.
How much will it cost me?
JVAL has an expense ratio of 0.12%, which means you’ll pay about $1.20 per year for every $1,000 invested. This cost is lower than the average stock ETF because JVAL is a passively managed, rules-based fund that tracks a value factor index instead of relying on expensive active stock-picking.
What would affect this ETF?
JVAL could benefit if U.S. economic growth stays solid and investors favor value stocks, especially in its heavy technology and health care holdings like Microsoft, Apple, and Johnson & Johnson, and if interest rates stabilize or fall, supporting large U.S. companies. On the downside, a slowdown in the U.S. economy, tighter regulations on big tech firms such as Meta and Alphabet, or rising interest rates that pressure stock valuations could hurt performance, particularly given its strong focus on U.S. large-cap tech names.
JVAL Top 10 Holdings
JVAL is essentially a U.S. large-cap value fund with a strong tech heartbeat, and its performance story starts there. Nvidia, Micron, and Apple have been rising, giving the ETF a solid lift as AI and chip demand stay in the spotlight. Microsoft and Alphabet are more mixed, occasionally losing steam and tempering some of that momentum. Broadcom has been lagging lately, acting as a small drag within the semiconductor cluster. With all holdings U.S.-based and tech-heavy, the fund’s fortunes are closely tied to the ups and downs of America’s biggest AI and cloud players.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Apple | 2.20% | $23.14M | $5.02T | 27.82% | 79Outperform | |
| Microsoft | 2.16% | $22.69M | $3.94T | -2.04% | 79Outperform | |
| Meta Platforms | 2.04% | $21.45M | $1.57T | -18.49% | 76Outperform | |
| Alphabet Class A | 1.92% | $20.21M | $3.96T | 21.47% | 85Outperform | |
| Micron | 1.85% | $19.49M | $1.11T | 343.08% | 79Outperform | |
| Nvidia | 1.78% | $18.73M | $5.19T | 7.14% | 76Outperform | |
| Broadcom | 1.72% | $18.09M | $1.68T | -5.67% | 76Outperform | |
| Johnson & Johnson | 1.62% | $17.07M | $652.48B | 45.00% | 78Outperform | |
| Merck & Company | 0.89% | $9.35M | $347.70B | 61.93% | 80Outperform | |
| Texas Instruments | 0.97% | $10.16M | $283.11B | 85.63% | 78Outperform |
JVAL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JVAL, the sentiment is Positive. The current price of 59.30 is above the 20-day moving average (MA) of 58.74, above the 50-day MA of 58.86, and above the 200-day MA of 55.06, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 56.94 is Neutral, neither overbought nor oversold. The STOCH value of 91.77 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JVAL.
JVAL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $59.30 | $65.00(9.61% Upside) | $1.05B | 0.12% | 72Outperform | |
| $83.00 | $96.39(16.13% Upside) | $7.38B | 0.44% | 71Outperform | |
| $41.82 | $48.01(14.80% Upside) | $7.36B | 0.21% | 73Outperform | |
| $231.07 | $260.40(12.69% Upside) | $6.93B | 0.07% | 72Outperform | |
| $113.91 | $128.76(13.04% Upside) | $3.89B | 0.20% | 73Outperform | |
| $43.00 | $48.87(13.66% Upside) | $3.65B | 0.18% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JVAL | JPMorgan U.S. Value Factor ETF | 59.30 | 11.95 | 25.25% | |
| JAVA | JPMorgan Active Value ETF | 83.00 | 14.51 | 21.18% | |
| DFLV | Dimensional US Large Cap Value ETF | 41.82 | 9.49 | 29.35% | |
| VOOV | Vanguard S&P 500 Value ETF | 231.07 | 32.80 | 16.55% | |
| IWX | iShares Russell Top 200 Value ETF | 113.91 | 26.37 | 30.13% | |
| FELV | Fidelity Enhanced Large Cap Value ETF | 43.00 | 9.79 | 29.47% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.